Supreme Hosts Grand Opening of 7ACRE Hybrid Greenhouse Facility

MARCH 30, 2016

TORONTO, ONTARIO — (Marketwired) — 03/30/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL) (OTC PINK:SPRWF) is pleased to report that yesterday over 100 residents, vendors, media representatives, employees and local dignitaries attended a grand opening event at Supreme’s 7 Acre Hybrid Greenhouse in Kincardine, Ontario. Representatives of all levels of local government were in attendance including MP Ben Lobb (Huron-Bruce); MPP Lisa Thompson (Huron-Bruce); Mayor Anne Eadie (Municipality of Kincardine); Warden Mitch Twolan (Bruce County); Warden Alan Barfoot (Grey County); Warden Paul Gowing (Huron County); and senior officials from the Town of Hanover, and the Townships of North Huron and Huron-Kinloss. The grand opening was an opportunity to celebrate the efforts of Supreme’s staff, local contractors, and local community members in obtaining the Marijuana for Medical Purposes (“MMPR”) license granted on March 11, 2016.

“Today is a great day for the Company and for Kincardine,” Mayor Eadie, remarked. “In 2014 Supreme came to town promising local employment and investment in our community. We are pleased they chose to put down roots in our Bruce Energy Centre and transform the existing greenhouse facility into a first rate operation. The Municipality of Kincardine looks forward to the next stage of Supreme’s business.” Ben Lobb, Member of Parliament for Huron-Bruce commented, “It has been a long process for the Company to obtain the MMPR license. I was impressed with the group’s dedication to their local community and unwavering commitment to become a licensed producer of sun grown, sustainable & affordable medical cannabis.”

Supreme is also pleased to announce the initial planting of seeds will occur this week, less than three weeks after receiving the MMPR License. “The grand opening of our 7 Acre hybrid greenhouse and the first planting of seeds are exciting milestones for Supreme,” stated John Fowler, President of Supreme. “Our team has executed our business plan with great skill, efficiency, and precision. Our license was obtained, without deficiencies, on a single inspection. Now we are moving to commence cultivation less than three weeks later. I have confidence in our ability to produce high quality sun grown product at a competitive cost and execute on our business plan.”

About Supreme

Supreme is a Canadian publically traded company committed to becoming a leading supplier of affordable medical cannabis through its wholly-owned subsidiary AMMCan. AMMCan is a federally licensed producer of medical marijuana pursuant to the MMPR operating a 7 Acre (342,000 sq. ft.) hybrid greenhouse facility. The Hybrid Greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit and for more information.


This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These risks and uncertainties include, but are not limited to, the Company’s ability to satisfy the conditions associated with its cultivation license, the Company’s ability to obtain a sales license and the related timing considerations, the availability of further financing, consumer interest in its products, competition, regulation, operational and technological risks, and anticipated and unanticipated costs and delays. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.

Supreme Pharmaceuticals Inc.
Investor Relations
202 – 20 De Boers Dr, Toronto ON M3J 0H1
(416) 630-7272

Source: Supreme Pharmaceuticals Inc.